Can CBD really help ease the pain?
The U.S. government is set to find out, as it will spend $3 million on scientific research of the compound, according to The Associated Press.
The National Center for Complementary and Integrative Health announced Thursday nine research grants to research “the potential pain-relieving properties and mechanisms of actions of the diverse phytochemicals in cannabis, including both minor cannabinoids and terpene.”
THC is not included in the research.
Chronic pain is the most common reason for which people turn to medical marijuana, despite a lack of scientific research about the exact parts of the plant that are helpful, according to the AP.
“The science is lagging behind the public use and interest. We’re doing our best to catch up here,” Dr. David Shurtleff, deputy director of the National Center for Complementary and Integrative Health, said in a statement.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
THC's potential for addiction and abuse make it an unsuitable pain medication, Shurtleff told the Associated Press, adding that the lack of marijuana research poses a public health risk.
One of the grant recipients, Dr. Judith Hellman from the University of California San Francisco, told the news agency that scientists need to understand pain better and develop more treatments.
“It’s very exciting to have the opportunity to do that,” she said.
Hellman’s research is focused on the body’s ability to create signaling molecules similar to marijuana’s ingredients.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.